TY - CHAP
T1 - Generation of Raw RPPA Data and Their Conversion to Analysis-Ready Data
AU - Akbani, Rehan
AU - Ling, Shiyun
AU - Lu, Yiling
N1 - Publisher Copyright:
© Springer Nature Singapore Pte Ltd 2019.
PY - 2019
Y1 - 2019
N2 - Reverse phase protein array (RPPA) provides investigators with a powerful high-throughput, quantitative, cost-effective technology for functional proteomics studies. It is an antibody-based technique with procedures similar to that of Western blots. RPPA has a wide variety of applications that range from pharmacodynamics and drug sensitivity assessment to biomarker discovery, subtype classification, and prediction of patient prognosis and response to targeted therapy. In this paper, we describe the technology, its limitations, and some solutions to overcome them. We discuss the steps necessary to obtain raw RPPA data and convert them into robust, high-quality, analysis-ready data. We then illustrate the utility of the platform by highlighting some biomarkers and drug responses of cancer cell lines that confirm previous findings, as a means to validate the platform and the methods presented here.
AB - Reverse phase protein array (RPPA) provides investigators with a powerful high-throughput, quantitative, cost-effective technology for functional proteomics studies. It is an antibody-based technique with procedures similar to that of Western blots. RPPA has a wide variety of applications that range from pharmacodynamics and drug sensitivity assessment to biomarker discovery, subtype classification, and prediction of patient prognosis and response to targeted therapy. In this paper, we describe the technology, its limitations, and some solutions to overcome them. We discuss the steps necessary to obtain raw RPPA data and convert them into robust, high-quality, analysis-ready data. We then illustrate the utility of the platform by highlighting some biomarkers and drug responses of cancer cell lines that confirm previous findings, as a means to validate the platform and the methods presented here.
KW - Antibody validation
KW - RPPA data generation
KW - RPPA normalization
KW - Raw RPPA data
UR - http://www.scopus.com/inward/record.url?scp=85076373269&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076373269&partnerID=8YFLogxK
U2 - 10.1007/978-981-32-9755-5_9
DO - 10.1007/978-981-32-9755-5_9
M3 - Chapter
C2 - 31820388
AN - SCOPUS:85076373269
T3 - Advances in Experimental Medicine and Biology
SP - 165
EP - 180
BT - Advances in Experimental Medicine and Biology
PB - Springer
ER -